Medical centers

Medical centers

Cetuximab Hypersensitivity in Patients with Alpha-Gal Sensitization

Research conducted by Vanderbilt University Medical Center has revealed a crucial link between the use of cetuximab, an antineoplastic monoclonal antibody, and hypersensitivity reactions in patients with asymptomatic alpha-gal sensitization. According to the study, a 66-year-old patient with metastatic squamous cell carcinoma experienced severe allergic reactions after receiving cetuximab, highlighting